Literature DB >> 632586

Anisakis and eosinophil. I. Detection of a soluble factor selectively chemotactic for eosinophils in the extract from Anisakis larvae.

J Tanaka, M Torisu.   

Abstract

Studies were undertaken in order to determine if Anisakis larva itself has the ability to attract eosinophils. Extracts from Anisakis larvae were examined for both neutrophil and eosinophil chemotactic activities with both in vivo and in vitro assay systems. When the soluble extract was injected intradermally into normal guinea pigs, a profound accumulation of eosinophils was observed at the injection site. The cells started to accumulate at the site within 1 hr and the number of eosinophils at the site reached its peak at 8 hr after the injection of the extract. Such eosinophilic accumulation was enhanced in a dose-response fashion over the range of 0.5 to 50 micrograms protein. The strong chemotatic activity of the Anisakis extract for eosinophils was confirmed when in vitro chemotaxis assays were performed with Boyden chemotatic chambers. Interestingly, no chemotactic activity for neutrophils was found at those concentrations of the extract with which the eosinophil effect was observed. These results indicate that the factor described here, in addition to the various known immunologic factors, may play an important role in the development of eosinophilia in anisakiasis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Necator americanus: the Na-ASP-2 protein secreted by the infective larvae induces neutrophil recruitment in vivo and in vitro.

Authors:  Molly A Bower; Stephanie L Constant; Susana Mendez
Journal:  Exp Parasitol       Date:  2007-12-04       Impact factor: 2.011

2.  A comparative study on eosinophil and neutrophil chemotactic activities of various helminth parasites.

Authors:  Y Horii; M Owhashi; K Fujita; H Nakanishi; A Ishii
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

Review 3.  The human eosinophil: roles in host defense and tissue injury.

Authors:  P F Weller; E J Goetzl
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

4.  Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis.

Authors:  Louis H Stein; Kevin M Redding; James J Lee; Thomas J Nolan; Gerhard A Schad; James B Lok; David Abraham
Journal:  J Innate Immun       Date:  2009-08-05       Impact factor: 7.349

Review 5.  Anisakiasis.

Authors:  J A Sakanari; J H McKerrow
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

6.  Mechanisms of eosinophil accumulation around eggs of Schistosoma japonicum: role of two purified components, allergen and eosinophil chemotactic factor, from soluble egg antigens measured on sensitized guinea pig skin.

Authors:  Y Horii; M Owhashi; A Ishii
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

7.  Neutrophil and eosinophil chemotactic factors in the excretory/secretory products of sheep abomasal nematode parasites: NCF and ECF in abomasal nematodes.

Authors:  Stefanie Reinhardt; Ian Scott; Heather V Simpson
Journal:  Parasitol Res       Date:  2011-03-19       Impact factor: 2.289

8.  Lethal efficacy of extract from Zingiber officinale (traditional Chinese medicine) or [6]-shogaol and [6]-gingerol in Anisakis larvae in vitro.

Authors:  C Goto; S Kasuya; K Koga; H Ohtomo; N Kagei
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

9.  Ascaris suum-derived products induce human neutrophil activation via a G protein-coupled receptor that interacts with the interleukin-8 receptor pathway.

Authors:  F H Falcone; A G Rossi; R Sharkey; A P Brown; D I Pritchard; R M Maizels
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 10.  Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity.

Authors:  M Teresa Audicana; Malcolm W Kennedy
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.